Replies to post #158611 on Biotech Values

[DewDiligence]

ENTA +23% on first day of trading. The enterprise value—based on ~19.5M fully-diluted shares and ~$110M of net cash—is about $250M.

[DewDiligence]

ENTA (20.44, +12%) is going wild, which probably means the HCV sector is in pre-EASL speculation mode. The stock is +46% from its IPO price only ten days ago, the market cap is now $400M, and the EV is about $300M (based on the arithmetic in #msg-85972531).

[DewDiligence]

ENTA sets new highs for intraday (22.17) and closing (21.69) prices; it’s now +55%(!) from the IPO price only three weeks ago. Pre-EASL enthusiasm, I suppose.